Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
19 hedge funds and large institutions have $3.75M invested in Strata Critical Medical Inc Warrants in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KC
Kepos Capital
New York
|
+$793K |
| 2 |
SRCM
Sage Rock Capital Management
New York
|
+$541K |
| 3 |
GL
Governors Lane
New York
|
+$467K |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$311K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$311K |
Top Sellers
SRTAW Hedge Fund Activity: Q1 2020 in Review
19 of the 4,548 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q1 2020, worth a combined $3.75M.
Buyers outnumbered sellers: 19 funds opened new SRTAW positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Kepos Capital, opening a new position worth an estimated $793K.
- 19 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q1 2020, up from 0 in Q4 2019.
- Funds reported $3.75M of Strata Critical Medical Inc Warrants stock for Q1 2020.
- 19 funds opened new Strata Critical Medical Inc Warrants positions in Q1 2020 and 0 closed out, a net change of +19 holders.
- The largest Strata Critical Medical Inc Warrants buyer in Q1 2020 was Kepos Capital, an estimated $793K added.
Based on aggregated 13F filings for Q1 2020.